Cargando…
Clinical Usefulness of Autoantibodies in Idiopathic Inflammatory Myositis
Autor principal: | García-De La Torre, Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4479798/ https://www.ncbi.nlm.nih.gov/pubmed/26161084 http://dx.doi.org/10.3389/fimmu.2015.00331 |
Ejemplares similares
-
Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
por: Amlani, Adam, et al.
Publicado: (2019) -
The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies
por: Rider, Lisa G., et al.
Publicado: (2013) -
Decreased Serum 25-(OH)-D Level Associated With Muscle Enzyme and Myositis Specific Autoantibodies in Patients With Idiopathic Inflammatory Myopathy
por: Yu, Zhen, et al.
Publicado: (2021) -
Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies
por: Li, Mengdi, et al.
Publicado: (2023) -
Autoantibodies in the pathogenesis of idiopathic inflammatory myopathies: Does the endoplasmic reticulum stress response have a role?
por: Corona-Sanchez, Esther Guadalupe, et al.
Publicado: (2022)